Skip to main content
Clinical Trials/DRKS00020813
DRKS00020813
Completed
Not Applicable

Cerebral oxygen saturation as an indicator of postoperative cardio-renal organ function and neurocognitive outcome in patients undergoing transcatheter aortic valve implantation.

Immanuel Klinikum Bernau, Herzzentrum Brandenburg0 sites146 target enrollmentDecember 12, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hemodynamic change and its outcome-relevant influence during transcatheter aortic valve implantation.
Sponsor
Immanuel Klinikum Bernau, Herzzentrum Brandenburg
Enrollment
146
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 12, 2022
End Date
June 1, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Immanuel Klinikum Bernau, Herzzentrum Brandenburg

Eligibility Criteria

Inclusion Criteria

  • Elective transcatheter aortic valve implantation (TAVI).
  • No contraindication to neurocognitive testing
  • Ability to understand the scope and significance of the study
  • Written informed consent to participate in the study

Exclusion Criteria

  • Emergency intervention
  • Dialysis patients
  • Patient (or proxy) is unable to provide written informed consent to participate in the
  • give written informed consent for participation in the study
  • Diseases, due to which neurocognitive testing is not possible
  • Attending physician does not recommend participation in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials